217
Participants
Start Date
September 21, 2023
Primary Completion Date
September 30, 2027
Study Completion Date
September 30, 2027
BGB-26808
Planned doses administered orally as a tablet daily.
Tislelizumab
Planned doses administered by intravenous infusion.
Chemotherapy
Administered in accordance with relevant local guidelines and/or prescribing information.
RECRUITING
Auckland City Hospital, Auckland
RECRUITING
Harbour Cancer and Wellness, Auckland
NOT_YET_RECRUITING
Health New Zealand Te Whatu Ora Lakes Rotorua Hospital, Rotorua
RECRUITING
Sylvester Cancer Center, University of Miami, Miami
NOT_YET_RECRUITING
University of Southern Californianorris Comprehensive, Los Angeles
RECRUITING
The First Hospital of China Medical University Hunnan Branch, Shenyang
RECRUITING
Harbin Medical University Cancer Hospital, Harbin
RECRUITING
Shanghai East Hospital Branch Hospital, Shanghai
COMPLETED
Shanghai Pulmonary Hospital, Shanghai
RECRUITING
The First Affiliated Hospital of Anhui Medical Universitygaoxin Branch, Hefei
RECRUITING
Yantai Yuhuangding Hospital, Yantai
RECRUITING
Jining No Peoples Hospital West Branch, Jining
RECRUITING
Hangzhou First Peoples Hospital, Hangzhou
COMPLETED
Taizhou Hospital of Zhejiang Province (East), Taizhou
RECRUITING
Hubei Cancer Hospital, Wuhan
RECRUITING
Tongji Hospital,Tongji Medical College of Hustsino French New City Branch, Wuhan
RECRUITING
Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital, Chengdu
NOT_YET_RECRUITING
City of Hope National Medical Center, Duarte
RECRUITING
Yale University, Yale Cancer Center, New Haven
NOT_YET_RECRUITING
University of Michigan, Ann Arbor
RECRUITING
John Theurer Cancer Center Hackensack University Medical Center, Hackensack
RECRUITING
Icahn School of Medicine At Mount Sinai, New York
RECRUITING
Providence Portland Medical Center, Portland
RECRUITING
The University of Texas Md Anderson Cancer Center, Houston
COMPLETED
Southside Cancer Care, Miranda
RECRUITING
Macquarie University, North Ryde
RECRUITING
Icon Cancer Centre Kurralta Park, Kurralta Park
RECRUITING
Linear Clinical Research, Nedlands
Lead Sponsor
BeiGene
INDUSTRY